H.C. Wainwright Reiterates Buy Rating on Armata Pharmaceuticals (ARMP)

September 22, 2026 7:36 AM

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating and $15.00 price target on Armata Pharmaceuticals (NYSE: ARMP).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found